SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran's potential blockbuster heart drug

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: xray who wrote (4)12/12/1996 10:38:00 AM
From: Chuca Marsh   of 27
 
I "Tuned" in and turned to todays news release-Congrads on your 2nd Patent
allowed /able from USA. Last year it was #921 and now #10XX. Both are
in the same novel class of new drugs, right, as both are arrym...ias.
Looks like your on to something, I apoligize . I was too, hard on
you folks. The condition you are researching is in the public interest and
should be given the opportunity to be supported. Even part time support
is better than no support ; at all!
Everyone , quite possibly, might know of someone who has passed
due to heart problems in general and Sudden Death Syndrom in particular.
I do/did and suspect my negative comments came from a place in my
heart that still had the emotional component of my personal grief.
I called my broker to put an order in this morning , he was out , so
I thought I'd write this first even though I might have to pay the higher
ask price -later! Good luck on the clinicals.
I do personally know how important US Patents are, I have personal
knowledge .
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext